Abstract
Objective
Physiologically mild-to-moderate FDG uptake of the spinal cord was reported. However, we noticed intense FDG uptake of distal spinal cord in several patients without definite spinal cord lesions on total-body PET/CT. Thus, this study aimed to investigate the frequency, pattern, intensity, and associations of FDG uptake in such cases on total-body PET/CT.
Methods
The clinical characteristics of age, gender, body mass index (BMI), lower extremity symptom, diabetes, and fasting blood glucose level, and total-body FDG PET/CT metabolic parameters of maximum standard uptake value (SUVmax), SUVmax of lean body mass (SUVlbm), and SUVmax of body surface area (SUVbsa), were retrospectively analyzed in 527 patients without definite spinal cord lesions. Intense FDG uptake was defined as greater than liver glucometabolism on visual analysis, and T5 cord was selected as cord background.
Results
Intense FDG uptake of distal spinal cord was observed in 87 out of 527 patients (16.5%) and involved with 2–3 vertebral segments including T11–T12 in 33 cases (38.0%), T12–L1 in 29 (33.3%), and T11–L1 in 25 (28.7%). No lesions were demonstrated on follow-up physical examinations, MRI or contrast-enhanced CT in these 87 cases with intense FDG accumulation in the distal spinal cord. The median SUVmax, SUVlbm, and SUVbsa of distal spinal cord with intense FDG uptake were 3.8 (2.7–5.5), 2.9 (2.2–4.3), and 1.0 (0.7–1.6), respectively. Significant differences in SUVmax, SUVlbm, and SUVbsa of distal cord and cord background were found between the groups with and without intense FDG uptake (P < 0.05). Moreover, significant differences in ratios of distal spinal cord-to-cord background, to mediastinal blood pool, and to liver were observed between two groups (P < 0.05). Intense FDG uptake of distal cord was associated with age, diabetic status, and blood glucose level.
Conclusions
Intense FDG uptake of distal spinal cord on total-body PET/CT may be physiological, more common in younger age, patients without diabetes, or lower fasting blood glucose.
Similar content being viewed by others
References
Bar-Shalom R, Valdivia AY, Blaufox MD. PET imaging in oncology. Semin Nucl Med. 2000;30:150–85.
Bomanji JB, Costa DC, Ell PJ. Clinical role of positron emission tomography in oncology. Lancet Oncol. 2001;2:157–64.
Hustinx R, Benard F, Alavi A. Whole-body FDG-PET imaging in the management of patients with cancer. Semin Nucl Med. 2002;32:35–46.
Amin A, Rosenbaum SJ, Bockisch A. Physiological (1)(8)F-FDG uptake by the spinal cord: is it a point of consideration for cancer patients? J Neurooncol. 2012;107:609–15.
Do BH, Mari C, Tseng JR, Quon A, Rosenberg J, Biswal S. Pattern of 18F-FDG uptake in the spinal cord in patients with non-c. Spine. 2011;36:E1395–401 ((Phila Pa 1976)).
Greenspan RL, Suprenant V, Atem F. Visualization of distal spinal cord on F-18 FDG PET/CT. Clin Nucl Med. 2012;37:137–41.
Guner LA, Unal K, Vardareli E, Kaya E, Temiz H, Dayioglu T. Physiological fluorodeoxyglucose uptake of spinal cord in adults. Nucl Med Commun. 2020;41:659–65.
Nakamoto Y, Tatsumi M, Hammoud D, Cohade C, Osman MM, Wahl RL. Normal FDG distribution patterns in the head and neck: PET/CT evaluation. Radiology. 2005;234:879–85.
Khan S, Son H. Spinal metastasis characterized on FDG PET/CT in head and neck squamous cell carcinoma. Clin Nucl Med. 2017;42:860–1.
Nguyen NC, Sayed MM, Taalab K, Osman MM. Spinal cord metastases from lung cancer: detection with F-18 FDG PET/CT. Clin Nucl Med. 2008;33:356–8.
Poggi MM, Patronas N, Buttman JA, Hewitt SM, Fuller B. Intramedullary spinal cord metastasis from renal cell carcinoma: detection by positron emission tomography. Clin Nucl Med. 2001;26:837–9.
Taralli S, Leccisotti L, Mattoli MV, Castaldi P, de Waure C, Mancuso A, et al. Physiological activity of spinal cord in children: An 18F-FDG PET-CT study. Spine. 2015;40:E647–52 ((Phila Pa 1976)).
Hoagey DA, Rieck JR, Rodrigue KM, Kennedy KM. Joint contributions of cortical morphometry and white matter microstructure in healthy brain aging: a partial least squares correlation analysis. Hum Brain Mapp. 2019;40:5315–29.
Myoraku A, Lang A, Taylor CT, Scott Mackin R, Meyerhoff DJ, Mueller S, et al. Age-dependent brain morphometry in major depressive disorder. Neuroimage Clin. 2021;33: 102924.
Alavi A, Saboury B, Nardo L, Zhang V, Wang M, Li H, et al. Potential and most relevant applications of total body PET/CT imaging. Clin Nucl Med. 2022;47:43–55.
Badawi RD, Shi H, Hu P, Chen S, Xu T, Price PM, et al. First human imaging studies with the EXPLORER total-body PET scanner. J Nucl Med. 2019;60:299–303.
Hu Y, Liu G, Yu H, Wang Y, Li C, Tan H, et al. Feasibility of ultra-low (18)F-FDG activity acquisitions using total-body PET/CT. J Nucl Med. 2021. https://doi.org/10.2967/jnumed.121.262038.
Nadig V, Herrmann K, Mottaghy FM, Schulz V. Hybrid total-body pet scanners-current status and future perspectives. Eur J Nucl Med Mol Imaging. 2022;49(2):445–59.
Tan H, Gu Y, Yu H, Hu P, Zhang Y, Mao W, et al. Total-body PET/CT: current applications and future perspectives. AJR Am J Roentgenol. 2020;215:325–37.
Cherry SR, Badawi RD, Karp JS, Moses WW, Price P, Jones T. Total-body imaging: transforming the role of positron emission tomography. Sci Transl Med. 2017;9(381):eaaf6169. https://doi.org/10.1126/scitranslmed.aaf6169.
Cherry SR, Jones T, Karp JS, Qi J, Moses WW, Badawi RD. Total-body PET: maximizing sensitivity to create new opportunities for clinical research and patient care. J Nucl Med. 2018;59:3–12.
Acknowledgements
This work was supported by the fund from the National Natural Science Foundation of China (81971645) and Guangdong Provincial People's Hospital (KY0120211130).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no competing financial interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Tan, X., Li, D., Wu, X. et al. Physiologically intense FDG uptake of distal spinal cord on total-body PET/CT. Ann Nucl Med 36, 643–650 (2022). https://doi.org/10.1007/s12149-022-01747-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12149-022-01747-3